drugset / Trial / NCT04135534
Find the Adequate Dose of Nalbuphine for Laparoscopic Cholecystectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluate the adequate dose of mutonpain for laparoscopic cholecystectomy in the management of post operative pain. The investigators will randomize patients into three groups to compare the analgesia effects and side effects.
Timeline
- Start
- 2019-11-01
- Primary completion
- 2020-11-01
- Completion
- 2020-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalbuphine | Small molecule | 0.05 mg/kg | — |
| Subject | Nalbuphine | Small molecule | 0.1 mg/kg | — |
| Subject | Nalbuphine | Small molecule | 0.2 mg/kg | — |
Indications
No indication recorded.